MIR4733HG
Basic information
Region (hg38): 17:31061720-31096045
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Neurofibromatosis, type 1 (121 variants)
- Hereditary cancer-predisposing syndrome;Cardiovascular phenotype (33 variants)
- not provided (21 variants)
- Neurofibromatosis-Noonan syndrome (19 variants)
- Café-au-lait macules with pulmonary stenosis (19 variants)
- Neurofibromatosis, familial spinal (19 variants)
- Cardiovascular phenotype;Hereditary cancer-predisposing syndrome (17 variants)
- Hereditary cancer-predisposing syndrome (10 variants)
- not specified (2 variants)
- Abnormality of the skin (1 variants)
- Neurofibromatosis, type 1;Neurofibromatosis, familial spinal;Neurofibromatosis-Noonan syndrome;Café-au-lait macules with pulmonary stenosis;Juvenile myelomonocytic leukemia (1 variants)
- Juvenile myelomonocytic leukemia;Neurofibromatosis, familial spinal;Neurofibromatosis-Noonan syndrome;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis, type 1 (1 variants)
- Neurofibromatosis, type 1;Neurofibromatosis-Noonan syndrome;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis, familial spinal;Juvenile myelomonocytic leukemia (1 variants)
- NF1-related condition (1 variants)
- Juvenile myelomonocytic leukemia (1 variants)
- Juvenile myelomonocytic leukemia;Neurofibromatosis, type 1;Neurofibromatosis-Noonan syndrome;Café-au-lait macules with pulmonary stenosis;Neurofibromatosis, familial spinal (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MIR4733HG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 24 | 72 | 39 | 145 | ||
Total | 24 | 9 | 73 | 39 | 1 |
Variants in MIR4733HG
This is a list of pathogenic ClinVar variants found in the MIR4733HG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-31094947-T-C | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal • Neurofibromatosis, type 1 • Neurofibromatosis-Noonan syndrome | Uncertain significance (Jan 12, 2018) | ||
17-31094988-G-A | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 • Neurofibromatosis, familial spinal | Uncertain significance (Jan 13, 2018) | ||
17-31095020-TGTGGGGAGACGGCGCTA-T | Neurofibromatosis, type 1 | Uncertain significance (Nov 28, 2023) | ||
17-31095030-C-T | Neurofibromatosis, type 1 | Uncertain significance (Nov 24, 2023) | ||
17-31095037-A-G | Neurofibromatosis, type 1 | Pathogenic (Dec 07, 2023) | ||
17-31095037-A-T | Neurofibromatosis, type 1 | Uncertain significance (Dec 16, 2021) | ||
17-31095038-G-A | Neurofibromatosis, type 1 | Conflicting classifications of pathogenicity (Sep 23, 2023) | ||
17-31095038-G-C | Neurofibromatosis, type 1 | Pathogenic (Sep 06, 2023) | ||
17-31095045-G-C | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal • Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 | Uncertain significance (Jan 12, 2018) | ||
17-31095059-C-T | Neurofibromatosis-Noonan syndrome • Neurofibromatosis, familial spinal • Neurofibromatosis, type 1 • Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 12, 2018) | ||
17-31095058-G-GCC | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal • Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 | Uncertain significance (Jun 14, 2016) | ||
17-31095058-G-GCCC | Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 • Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal | Uncertain significance (Jun 14, 2016) | ||
17-31095064-T-TC | Neurofibromatosis-Noonan syndrome • Neurofibromatosis, familial spinal • Neurofibromatosis, type 1 • Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jun 14, 2016) | ||
17-31095069-T-TC | Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 • Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal | Uncertain significance (Jun 14, 2016) | ||
17-31095073-C-T | Neurofibromatosis-Noonan syndrome • Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal • Neurofibromatosis, type 1 | Uncertain significance (Jan 13, 2018) | ||
17-31095081-C-G | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, type 1 • Neurofibromatosis, familial spinal • Neurofibromatosis-Noonan syndrome | Uncertain significance (Jan 13, 2018) | ||
17-31095101-C-A | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, type 1 • Neurofibromatosis, familial spinal • Neurofibromatosis-Noonan syndrome | Uncertain significance (Jan 13, 2018) | ||
17-31095137-C-G | Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 • Neurofibromatosis, familial spinal • Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 12, 2018) | ||
17-31095144-T-C | Neurofibromatosis-Noonan syndrome • Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, type 1 • Neurofibromatosis, familial spinal | Uncertain significance (Jan 13, 2018) | ||
17-31095162-C-A | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, type 1 • Neurofibromatosis-Noonan syndrome • Neurofibromatosis, familial spinal • Juvenile myelomonocytic leukemia;Neurofibromatosis-Noonan syndrome;Neurofibromatosis, familial spinal;Neurofibromatosis, type 1;Café-au-lait macules with pulmonary stenosis | Uncertain significance (Oct 27, 2021) | ||
17-31095195-T-C | Neurofibromatosis-Noonan syndrome • Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal • Neurofibromatosis, type 1 | Uncertain significance (Jan 13, 2018) | ||
17-31095226-C-T | Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 • Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal | Uncertain significance (Jan 12, 2018) | ||
17-31095237-G-T | Neurofibromatosis, type 1 • Neurofibromatosis, familial spinal • Neurofibromatosis-Noonan syndrome • Café-au-lait macules with pulmonary stenosis | Uncertain significance (Jan 13, 2018) | ||
17-31095259-C-T | Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, familial spinal • Neurofibromatosis-Noonan syndrome • Neurofibromatosis, type 1 • not specified | Uncertain significance (Apr 15, 2024) | ||
17-31095288-G-C | not specified • Neurofibromatosis, familial spinal • Neurofibromatosis-Noonan syndrome • Café-au-lait macules with pulmonary stenosis • Neurofibromatosis, type 1 | Benign/Likely benign (Aug 01, 2024) |
GnomAD
Source:
dbNSFP
Source: